HEPION PHARMACEUTICALS INC's ticker is HEPA and the CUSIP is 426897104. A total of 31 filers reported holding HEPION PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $44,646 | +158.4% | 57,534 | -0.1% | 0.00% | – |
Q4 2022 | $17,278 | -40.4% | 57,594 | +0.1% | 0.00% | – |
Q3 2022 | $29,000 | -12.1% | 57,534 | 0.0% | 0.00% | – |
Q2 2022 | $33,000 | -55.4% | 57,534 | 0.0% | 0.00% | – |
Q1 2022 | $74,000 | +12.1% | 57,534 | 0.0% | 0.00% | – |
Q4 2021 | $66,000 | +10.0% | 57,534 | +47.4% | 0.00% | – |
Q3 2021 | $60,000 | – | 39,034 | +134500.0% | 0.00% | – |
Q3 2019 | $0 | – | 29 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
PVG ASSET MANAGEMENT CORP | 189,616 | $375,439,000 | 1.17% |
Ikarian Capital, LLC | 1,365,059 | $2,703,000 | 0.22% |
Altium Capital Management LP | 446,000 | $883,000 | 0.20% |
ASSET MANAGEMENT CORP /IL/ /ADV | 91,500 | $181,000 | 0.10% |
Virtu Financial LLC | 113,869 | $225,000 | 0.02% |
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 10,000 | $20,000 | 0.01% |
BOOTHBAY FUND MANAGEMENT, LLC | 155,069 | $307,000 | 0.01% |
McAdam, LLC | 55,978 | $86,000 | 0.01% |
Moloney Securities Asset Management, LLC | 27,340 | $54,000 | 0.01% |
Allen Capital Group, LLC | 23,685 | $47,000 | 0.01% |